highly significantP < .001
The RA + group had a highly significant occurrence of total day 3 AKI (74.1% vs 10.6%) and severe AKI on day 3 (60.6% vs 4.2%), based on KDIGO stage 2 and 3 ( P < .001).
The RA + group had a highly significant occurrence of total day 3 AKI (74.1% vs 10.6%) and severe AKI on day 3 (60.6% vs 4.2%), based on KDIGO stage 2 and 3 ( P < .001).